Skip to main content
. 2017 May 31;22(6):913. doi: 10.3390/molecules22060913

Figure 1.

Figure 1

The structures of some multi-targeted kinase inhibitors. Some inhibitors, such as semaxanib, orantinib, and sunitinib, share a common structure of (2-oxindolin-3-ylidene)methylpyrrole nucleus.